4/16
07:00 am
axgn
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
Low
Report
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
4/4
08:10 am
axgn
Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long [Yahoo! Finance]
Medium
Report
Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long [Yahoo! Finance]
3/9
12:17 am
axgn
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) [Yahoo! Finance]
Medium
Report
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) [Yahoo! Finance]
3/8
05:52 am
axgn
US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results [Yahoo! Finance]
Low
Report
US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results [Yahoo! Finance]
3/6
08:32 am
axgn
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
07:51 am
axgn
AxoGen Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
AxoGen Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
3/5
06:34 pm
axgn
Health Care Down After Mixed Earnings -- Health Care Roundup [MarketWatch]
Medium
Report
Health Care Down After Mixed Earnings -- Health Care Roundup [MarketWatch]
3/5
11:50 am
axgn
Axogen Shares Fall 13% on Lukewarm 2024 Outlook [MarketWatch]
Low
Report
Axogen Shares Fall 13% on Lukewarm 2024 Outlook [MarketWatch]
3/5
07:44 am
axgn
Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023 [Yahoo! Finance]
High
Report
Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023 [Yahoo! Finance]
3/5
07:00 am
axgn
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
High
Report
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
2/28
10:26 am
axgn
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Low
Report
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
2/28
02:04 am
axgn
AxoGen, Inc. (NASDAQ: AXGN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
AxoGen, Inc. (NASDAQ: AXGN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/26
11:03 am
axgn
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue? [Yahoo! Finance]
Low
Report
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue? [Yahoo! Finance]
2/20
11:03 pm
axgn
AxoGen, Inc. (NASDAQ: AXGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
AxoGen, Inc. (NASDAQ: AXGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/20
07:21 am
axgn
Zacks.com featured highlights AxoGen, Western Digital and Gen Digital [Yahoo! Finance]
Low
Report
Zacks.com featured highlights AxoGen, Western Digital and Gen Digital [Yahoo! Finance]
2/13
04:30 pm
axgn
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
Low
Report
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
2/9
10:02 pm
axgn
AxoGen, Inc. (NASDAQ: AXGN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
AxoGen, Inc. (NASDAQ: AXGN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/6
11:34 am
axgn
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
2/2
04:15 pm
axgn
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Low
Report
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
1/30
02:45 am
axgn
Nerve Repair and Regeneration Market is expected to develop at a USD 32.4 Billion by 2033 | Riding on a Strong 13.4% CAGR [Yahoo! Finance]
Medium
Report
Nerve Repair and Regeneration Market is expected to develop at a USD 32.4 Billion by 2033 | Riding on a Strong 13.4% CAGR [Yahoo! Finance]
1/26
10:29 am
axgn
Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength [Yahoo! Finance]
Low
Report
Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength [Yahoo! Finance]
1/21
04:52 pm
axgn
Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS [Seeking Alpha]
Low
Report
Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS [Seeking Alpha]